The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities

Secondary acute myeloid leukemia (sAML) includes AML as a complication of an antecedent hematological disorder or a therapy‐related AML. Large registry‐based data identified sAML as an independent poor‐outcome type of AML post allogeneic hematopoietic cell transplantation (allo‐HCT). In our study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanein, Mona, Fakih, Riad El, Rasheed, Walid, Ahmed, Syed, Shaheen, Marwan, Chaudhri, Naeem, Alsharif, Fahad, Ahmed, Shad, Hanbali, Amr, AlShaibani, Alfadel, Alfraih, Feras, Alhayli, Saud, Elhassan, Tusneem, Alahmari, Ali, Alzahrani, Hazzaa, Almohareb, Fahad, Aljurf, Mahmoud, Hashmi, Shahrukh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Transplant and Cellular Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175943/
https://www.ncbi.nlm.nih.gov/pubmed/35845278
http://dx.doi.org/10.1002/jha2.136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175943/
https://www.ncbi.nlm.nih.gov/pubmed/35845278
http://dx.doi.org/10.1002/jha2.136

Ejemplares similares